Literature DB >> 25034763

A naturalistic longitudinal study of at-risk mental state with a 2.4 year follow-up at a specialized clinic setting in Japan.

Masahiro Katsura1, Noriyuki Ohmuro2, Chika Obara3, Tatsuo Kikuchi3, Fumiaki Ito4, Tetsuo Miyakoshi5, Hiroo Matsuoka6, Kazunori Matsumoto7.   

Abstract

OBJECTIVE: The notion of at-risk mental state (ARMS) is valuable for identifying individuals in a putative prodromal state of psychosis and for reducing conversion risk by pharmacological and psychological interventions. However, further systematic study is required because 1) diagnostic reliability in various clinical settings is not yet established; 2) predictive ability is insufficient; 3) optimal interventions in diversified populations are elusive; and 4) little evidence from non-Western regions exists.
METHODS: A naturalistic longitudinal study was conducted at a specialized clinic for early psychosis at a university hospital in Sendai, Japan. Individuals with ARMS (n=106) were recruited and followed up with case-by-case treatment.
RESULTS: Two-thirds of the participants were psychiatrist referrals, and 83 were followed up for at-least 1 year (mean follow-up=2.4 years). Fourteen developed psychosis and the estimated (by Kaplan-Meier) cumulative transition rate was 11.1% at 12, 15.4% at 24, and 17.5% at 30 months. At the end-point, about 30% of the 83 followed-up participants including 11 converters received antipsychotic medication. Compared to non-converters, converters showed more severe attenuated psychotic symptoms, including ego-boundary disturbance, formal thought disorder, and emotional disturbance.
CONCLUSIONS: The present study replicated previous major Western longitudinal studies, in terms of clinical characteristics, psychosis transition rate, and antipsychotic prescription rate. Our results emphasize the importance of phenomenological assessment of ARMS and intensive care in a clinical setting.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antipsychotics; Clinical high risk; Early intervention; Psychosis; Schizophrenia; Ultra-high risk (UHR)

Mesh:

Year:  2014        PMID: 25034763     DOI: 10.1016/j.schres.2014.06.013

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  16 in total

1.  The cognitive aspect of formal thought disorder and its relationship with global social functioning and the quality of life in schizophrenia.

Authors:  Emre Mutlu; Hatice Abaoğlu; Elif Barışkın; Ş Can Gürel; Aygün Ertuğrul; M Kazım Yazıcı; Esra Akı; A Elif Anıl Yağcıoğlu
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2021-01-17       Impact factor: 4.328

2.  Treatment Precedes Positive Symptoms in North American Adolescent and Young Adult Clinical High Risk Cohort.

Authors:  Kristen A Woodberry; Larry J Seidman; Caitlin Bryant; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Thomas H McGlashan; Daniel H Mathalon; Diana O Perkins; Ming T Tsuang; Elaine F Walker; Scott W Woods
Journal:  J Clin Child Adolesc Psychol       Date:  2016-10-05

3.  Thought Disorder in Schizophrenia and Bipolar Disorder Probands, Their Relatives, and Nonpsychiatric Controls.

Authors:  Charity J Morgan; Michael J Coleman; Ayse Ulgen; Lenore Boling; Jonathan O Cole; Frederick V Johnson; Jan Lerbinger; J Alexander Bodkin; Philip S Holzman; Deborah L Levy
Journal:  Schizophr Bull       Date:  2017-05-01       Impact factor: 9.306

4.  Does hallucination perceptual modality impact psychosis risk?

Authors:  H F Niles; B C Walsh; S W Woods; A R Powers
Journal:  Acta Psychiatr Scand       Date:  2019-08-16       Impact factor: 6.392

5.  Neural Dysfunction in Cognitive Control Circuits in Persons at Clinical High-Risk for Psychosis.

Authors:  Tiziano Colibazzi; Guillermo Horga; Zhishun Wang; Yuankai Huo; Cheryl Corcoran; Kristin Klahr; Gary Brucato; Ragy Girgis; Kelly Gill; Anissa Abi-Dargham; Bradley S Peterson
Journal:  Neuropsychopharmacology       Date:  2015-09-10       Impact factor: 7.853

6.  Severity of thought disorder predicts psychosis in persons at clinical high-risk.

Authors:  Diana O Perkins; Clark D Jeffries; Barbara A Cornblatt; Scott W Woods; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Tyrone D Cannon; Robert Heinssen; Daniel H Mathalon; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Thomas H McGlashan
Journal:  Schizophr Res       Date:  2015-10-04       Impact factor: 4.939

Review 7.  Forecasting Remission From the Psychosis Risk Syndrome With Mismatch Negativity and P300: Potentials and Pitfalls.

Authors:  Holly K Hamilton; Brian J Roach; Daniel H Mathalon
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2020-10-24

8.  Criticism and Depression among the Caregivers of At-Risk Mental State and First-Episode Psychosis Patients.

Authors:  Yumiko Hamaie; Noriyuki Ohmuro; Masahiro Katsura; Chika Obara; Tatsuo Kikuchi; Fumiaki Ito; Tetsuo Miyakoshi; Hiroo Matsuoka; Kazunori Matsumoto
Journal:  PLoS One       Date:  2016-02-26       Impact factor: 3.240

9.  Polygenic Risk Score Contribution to Psychosis Prediction in a Target Population of Persons at Clinical High Risk.

Authors:  Diana O Perkins; Loes Olde Loohuis; Jenna Barbee; John Ford; Clark D Jeffries; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Daniel H Mathalon; Thomas H McGlashan; Larry J Seidman; Ming Tsuang; Elaine F Walker; Scott W Woods
Journal:  Am J Psychiatry       Date:  2019-11-12       Impact factor: 18.112

10.  Aberrant Temporal Connectivity in Persons at Clinical High Risk for Psychosis.

Authors:  Tiziano Colibazzi; Zhen Yang; Guillermo Horga; Yan Chao-Gan; Cheryl M Corcoran; Kristin Klahr; Gary Brucato; Ragy Girgis; Anissa Abi-Dargham; Michael P Milham; Bradley S Peterson
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2017-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.